The commodification of breast cancer goes all the way to our genes. Most people are shocked and puzzled to learn that one company, Myriad Genetics, holds a patent on the human BRCA1 and BRCA2 genes—often known as “the breast cancer genes”.
How does a corporation hold a patent on a human gene that exists in every single person? How can a company claim to own a naturally occurring part of your and my genetic code?
Click the link above to read the entire article as written by Karuna Jaggar.